Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome

Ann Intern Med. 1985 Feb;102(2):189-93. doi: 10.7326/0003-4819-102-2-189.

Abstract

Seven Haitian and one white patient with the acquired immunodeficiency syndrome and Salmonella typhimurium bacteremia were identified over a 28-month period. In three patients bacteremia developed concurrently with an opportunistic infection associated with the acquired immunodeficiency syndrome. The remaining five patients had their initial episodes of bacteremia 3 to 11 months before the diagnosis of the acquired immunodeficiency syndrome. These five patients had signs suggestive of the syndrome, plus evidence of disordered cellular immune function (lymphopenia, anergy, decreased T-helper cells, decreased proliferative responses, and a deficiency in mononuclear-cell alpha interferon production). Salmonella typhimurium bacteremia in the appropriate clinical setting may be an opportunistic pathogen associated with the acquired immunodeficiency syndrome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adult
  • Ampicillin / therapeutic use
  • Chloramphenicol / therapeutic use
  • Diarrhea / etiology
  • Drug Combinations / therapeutic use
  • Female
  • Haiti / ethnology
  • Humans
  • Male
  • New York City
  • Recurrence
  • Salmonella Infections / etiology*
  • Salmonella Infections / immunology
  • Salmonella typhimurium
  • Sepsis / etiology*
  • Sepsis / immunology
  • Sulfamethoxazole / therapeutic use
  • Trimethoprim / therapeutic use
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Drug Combinations
  • Chloramphenicol
  • Ampicillin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Trimethoprim
  • Sulfamethoxazole